• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

作者更正：亚致敏CD8细胞中的PD-1阻断诱导功能失调的PD-1⁺CD38⁺细胞和抗PD-1耐药性。

Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1CD38 cells and anti-PD-1 resistance.

作者信息

Verma Vivek, Shrimali Rajeev K, Ahmad Shamim, Dai Winjie, Wang Hua, Lu Sumin, Nandre Rahul, Gaur Pankaj, Lopez Jose, Sade-Feldman Moshe, Yizhak Keren, Bjorgaard Stacey L, Flaherty Keith T, Wargo Jennifer A, Boland Genevieve M, Sullivan Ryan J, Getz Gad, Hammond Scott A, Tan Ming, Qi Jingjing, Wong Phillip, Merghoub Taha, Wolchok Jedd, Hacohen Nir, Janik John E, Mkrtichyan Mikayel, Gupta Seema, Khleif Samir N

机构信息

Georgia Cancer Center, Augusta University, Augusta, GA, USA.

The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

出版信息

Nat Immunol. 2019 Nov;20(11):1555. doi: 10.1038/s41590-019-0519-6.

DOI:10.1038/s41590-019-0519-6
PMID:31551574
Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

摘要

本文的一个修订版本已发表，可通过本文顶部的链接获取。

相似文献

1
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1CD38 cells and anti-PD-1 resistance.作者更正：亚致敏CD8细胞中的PD-1阻断诱导功能失调的PD-1⁺CD38⁺细胞和抗PD-1耐药性。
Nat Immunol. 2019 Nov;20(11):1555. doi: 10.1038/s41590-019-0519-6.
2
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1CD38 cells and anti-PD-1 resistance.PD-1 阻断在亚初始 CD8 细胞中诱导功能失调的 PD-1CD38 细胞和抗 PD-1 耐药性。
Nat Immunol. 2019 Sep;20(9):1231-1243. doi: 10.1038/s41590-019-0441-y. Epub 2019 Jul 29.
3
Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells.作者更正：选择性组蛋白去乙酰化酶6（HDAC6）抑制剂通过降低巨噬细胞的抗炎表型和下调肿瘤细胞中的免疫抑制蛋白来改善抗程序性死亡蛋白1（PD-1）免疫检查点阻断疗法。
Sci Rep. 2019 Oct 10;9(1):14824. doi: 10.1038/s41598-019-51403-6.
4
Author Correction: Subsets of exhausted CD8 T cells differentially mediate tumor control and respond to checkpoint blockade.作者更正：耗竭性CD8 T细胞亚群以不同方式介导肿瘤控制并对检查点阻断作出反应。
Nat Immunol. 2019 Nov;20(11):1556. doi: 10.1038/s41590-019-0528-5.
5
Author Correction: Improved ethanol electrooxidation performance by shortening Pd-Ni active site distance in Pd-Ni-P nanocatalysts.作者更正：通过缩短Pd-Ni-P纳米催化剂中Pd-Ni活性位点间距提高乙醇电氧化性能
Nat Commun. 2020 Mar 9;11(1):1333. doi: 10.1038/s41467-020-15019-z.
6
Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.作者更正：PD-1/PD-L1抑制剂治疗晚期非小细胞肺癌的真实世界证据及临床观察
Sci Rep. 2020 Jan 27;10(1):1525. doi: 10.1038/s41598-020-58487-5.
7
CD38 identifies pre-activated CD8+ T cells which can be reinvigorated by anti-PD-1 blockade in human lung cancer.CD38 鉴定了预先激活的 CD8+T 细胞，这些细胞可以通过抗 PD-1 阻断在人类肺癌中重新激活。
Cancer Immunol Immunother. 2021 Dec;70(12):3603-3616. doi: 10.1007/s00262-021-02949-w. Epub 2021 May 2.
8
Author Correction: Regulation of sister chromatid cohesion by nuclear PD-L1.作者更正：细胞核程序性死亡配体1对姐妹染色单体黏连的调控
Cell Res. 2020 Sep;30(9):823. doi: 10.1038/s41422-020-0365-y.
9
Author Correction: Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL.作者更正：表达程序性死亡受体配体1（PD-L1）的B细胞数量增加与艾滋病相关非霍奇金淋巴瘤（AIDS-NHL）的发生有关。
Sci Rep. 2020 Jan 15;10(1):748. doi: 10.1038/s41598-020-57442-8.
10
Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.作者更正：免疫基因组分析确定卵巢癌对PARP与PD-1联合抑制的反应。
Nat Commun. 2020 May 18;11(1):2543. doi: 10.1038/s41467-020-16344-z.

引用本文的文献

1
Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy.通过新型生物活性纳米疫苗重塑肿瘤免疫抑制微环境可增强癌症免疫治疗的疗效。
Bioact Mater. 2022 Mar 11;16:107-119. doi: 10.1016/j.bioactmat.2022.03.008. eCollection 2022 Oct.
2
A cascade targeting strategy based on modified bacterial vesicles for enhancing cancer immunotherapy.基于改良细菌囊泡的级联靶向策略增强癌症免疫治疗。
J Nanobiotechnology. 2021 Dec 20;19(1):434. doi: 10.1186/s12951-021-01193-9.
3
Immunological Network in Head and Neck Squamous Cell Carcinoma-A Prognostic Tool Beyond HPV Status.
头颈部鳞状细胞癌中的免疫网络——超越人乳头瘤病毒状态的一种预后工具
Front Oncol. 2020 Sep 15;10:1701. doi: 10.3389/fonc.2020.01701. eCollection 2020.